Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.

Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Abstract Text:

Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: British medical journal

VOLUME: 1

Page Numbers: 1396

Journal Abbreviation: Br Med J

ISSN: 0007-1447

DAY: 27

MONTH: May

YEAR: 1978

Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372673

Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Keywords Mesh Terms:

KEYWORDS: Middle Aged

MESH TERMS: analysis

Chemical & Substance for Abstract: Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. Information

Substance Name: C-Reactive Protein

Registry Number: 9007-41-4

Grant and Affiliation Information for Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br Med J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment Related Publications

• 20S ways to apoptosis.
• A novel role for a familiar protein in apoptosis induced by proteasome inhibition.
• Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
• Chuei-Fong-Tou-Geu-Wan in rheumatoid arthritis.
• Combination therapy with IFN-alpha plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells.
• Detection of polarized light in the vacuum UV.
• Drugs and rheumatoid arthritis.
• Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia.
• Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
• Frontline care in Irish intellectual disability services: The contribution of nurses and non-nurse care staff.
• If I had...Severe rheumatoid arthritis.
• Insulin oedema.
• Interferon-alpha Induces TRAIL Expression and Cell Death Via an IRF-1-Dependent Mechanism in Human Bladder Cancer Cells.
• Metabolic reconstruction and analysis for parasite genomes.
• Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA.
• Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
• Osteoporosis and long-term corticosteroid therapy.
• Polarization analysis techniques in the VUV.
• Production and measurement of circular polarization in the VUV.
• Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.
• Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.
• Therapy-induced apoptosis in primary tumors.
• Variations in the polarization sensitivity of microchannel plates with photon incidence angle and wavelength in the VUV.